Ö. ACAR Et Al. , "Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer," Turkish Journal of Clinics and Laboratory , vol.1, no.1861167, pp.1-8, 2026
ACAR, Ö. Et Al. 2026. Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer. Turkish Journal of Clinics and Laboratory , vol.1, no.1861167 , 1-8.
ACAR, Ö., AYGÖR KABASAKAL, E., ŞAHBAZLAR, M., EKİNCİ, F., & ERDOĞAN, A. P., (2026). Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer. Turkish Journal of Clinics and Laboratory , vol.1, no.1861167, 1-8.
ACAR, ÖMER Et Al. "Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer," Turkish Journal of Clinics and Laboratory , vol.1, no.1861167, 1-8, 2026
ACAR, ÖMER Et Al. "Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer." Turkish Journal of Clinics and Laboratory , vol.1, no.1861167, pp.1-8, 2026
ACAR, Ö. Et Al. (2026) . "Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer." Turkish Journal of Clinics and Laboratory , vol.1, no.1861167, pp.1-8.
@article{article, author={ÖMER ACAR Et Al. }, title={Survival outcomes according to adjuvant chemotherapy duration and oxaliplatin use in patients aged 70 years and older with stage II–III colon cancer}, journal={Turkish Journal of Clinics and Laboratory}, year=2026, pages={1-8} }